Leukemia: all 5,475 studies
Page 1 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of a Smart Holistic Health Care Platform Intervention on Cancer Children and Parents' Bio-Psycho-Social and Spiritual HealthRecruitingNCT07805096Not applicable
- Musculoskeletal Ultrasound in Patients With Hematologic MalignanciesNot yet recruitingNCT07785505
- A Clinical Study of HY035 Cell Injection in the Treatment of CD7-positive Relapsed or Refractory Hematologic MalignanciesEnrolling by invitationNCT07784309Phase 1
- A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AMLRecruitingNCT07751991Phase 1
- Efficacy of Seated Exercise on Functional Capacity and Quality of Life in Patients With Leukemia During Chemotherapy CyclesNot yet recruitingNCT07740174Not applicable
- Dyadic Physical Activity Intervention for Children Undergoing Cancer TreatmentNot yet recruitingNCT07737418Not applicable
- The AYA Oncology Self-care MovementNot yet recruitingNCT07724652Not applicable
- Rutgers University Study of the Genetics of Blood CancersRecruitingNCT07714044
- Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic MalignanciesNot yet recruitingNCT07710781Not applicable
- Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell TransplantationNot yet recruitingNCT07698080Phase 2
- Addressing Cancer Care Equity With Social Determinants of Health Screening and Early InterventionRecruitingNCT07671209Not applicable
- Anti-CD33-CLL1 CAR-T Cells (ICG415) for the Treatment of Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT07668557Phase 1
- Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)RecruitingNCT07634653Not applicable
- Digitalized Exercise Fit Tool Intervention for Adolescents With Blood CancerNot yet recruitingNCT07621887Not applicable
- A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute Lymphoblastic Leukemia (ALL)Not yet recruitingNCT07614022Phase 1
- Stepped-Care Support for Children With LeukaemiaEnrolling by invitationNCT07587411Not applicable
- First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.RecruitingNCT07586618Phase 1
- Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell TransplantationRecruitingNCT07573111Phase 1
- Cord Blood Transplantation in Children and Young Adults With Blood CancerRecruitingNCT07566377Phase 2
- Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood CancersNot yet recruitingNCT07524530Phase 2
- Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or NeuroblastomaNot yet recruitingNCT07518654Phase 1
- Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.Not yet recruitingNCT07518329Phase 1
- Cohort of Patients With Chronic Myelomonocytic LeukemiaRecruitingNCT07512882
- Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)RecruitingNCT07509151Phase 3
- Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic LeukemiaRecruitingNCT07504458Phase 3
- HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy SurvivorsNot yet recruitingNCT07483749
- CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT07464951Phase 1
- Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer SurvivorsRecruitingNCT07450872
- Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid LeukemiaRecruitingNCT07439211Phase 1
- Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic LeukemiaRecruitingNCT07429461Early Phase 1
- This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including RNot yet recruitingNCT07412405Not applicable
- EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid TumorsRecruitingNCT07410676Phase 1/2
- Spiritual Care Intervention in Adult Patients Diagnosed With Acute LeukemiaRecruitingNCT07405424Not applicable
- Study With Tocilizumab in Combination With Venetoclax and Azacitidine Chemotherapy in Patients With Acute Myeloid LeukemiaNot yet recruitingNCT07392814Phase 1
- Weight Gain in Pediatric Leukemia SurvivorsNot yet recruitingNCT07374315Not applicable
- Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell LymphomaRecruitingNCT07356245Phase 2
- A Study of Revumenib and Mezigdomide in People With LeukemiaRecruitingNCT07356154Phase 1/2
- Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CPRecruitingNCT07354074Phase 2
- A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological MalignanciesRecruitingNCT07347171Phase 1
- Natural History Study of Early Life Exposures in Agriculture (ELEA)Enrolling by invitationNCT07328516
- A Nurse-led Multicomponent Interventional Protocol to Improve Sleep Quality in Paediatric Oncology PatientsRecruitingNCT07323069Not applicable
- Randomised Controlled Trial of Artificial Intelligence-assisted Health EducationRecruitingNCT07305337Not applicable
- Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R LeukemiaRecruitingNCT07297173Phase 1
- A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301)Not yet recruitingNCT07296445Phase 3
- CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBLRecruitingNCT07294677Phase 1/2
- Halt Aging in Survivors of Blood CancersRecruitingNCT07292272Not applicable
- Patient-Reported Outcomes in Allogeneic Stem Cell Transplantation and CAR-T TherapyNot yet recruitingNCT07289087
- Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell MalignanciesRecruitingNCT07284433Phase 1/2
- Improving Chemotherapy Induced Peripheral Neuropathy in Children With Leukemia: A Study of Transcutaneous Acupoints Electrical Stimulation and Auricular Acupressure InterventionsNot yet recruitingNCT07279818Not applicable
- Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic MalignanciesRecruitingNCT07270263Not applicable
- Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic LeukemiaRecruitingNCT07258043
- Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell TransplantationRecruitingNCT07256210Phase 2
- Study of NK Cells in the Monitoring of Patients With Acute Leukemia or MyelodysplasiaNot yet recruitingNCT07249476
- Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell TransplantationRecruitingNCT07249346Phase 2
- ALL Backbone in AYAsRecruitingNCT07227584Phase 2
- Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeRecruitingNCT07216443Phase 2
- High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)RecruitingNCT07205523
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)RecruitingNCT07202091Phase 2/3
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)RecruitingNCT07202078Phase 2/3
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)RecruitingNCT07202065Phase 2/3
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)RecruitingNCT07202052Phase 2/3
- What is the Impact of TKI on Thyroid Function in CML Patients?Not yet recruitingNCT07200882
- HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesNot yet recruitingNCT07175415Phase 1/2
- xDRIVE for Florida-based Cancer PatientsRecruitingNCT07167381Not applicable
- Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AMLNot yet recruitingNCT07157514Phase 2/3
- A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and VenetoclaxRecruitingNCT07148180Phase 1/2
- Expression Pattern and Possible Clinical Significance of CD81 In Myeloid LeukemiaNot yet recruitingNCT07146542
- A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell MalignanciesRecruitingNCT07135466Phase 1/2
- Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological MalignanciesNot yet recruitingNCT07131449
- Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory LeukemiaNot yet recruitingNCT07120607Phase 1
- A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic MalignanciesNot yet recruitingNCT07107204Phase 1/2
- Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic LeukemiaRecruitingNCT07105579Phase 2
- Cardiovascular Risk in Children With Chronic Conditions StudyRecruitingNCT07086989
- A Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Standard Continuous Venetoclax Exposure Combined With Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Intensive InductionNot yet recruitingNCT07082452Phase 3
- Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease MarkerRecruitingNCT07060001Phase 2
- A Music Therapy Study for Blood Cancer Survivors With Cognitive DifficultiesRecruitingNCT07052916Not applicable
- Mosunetuzumab for CLL MRD ClearanceRecruitingNCT07052695Phase 1/2
- Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and FeverRecruitingNCT07051525Not applicable
- Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid MalignanciesRecruitingNCT07044544Phase 1
- A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid LeukemiaRecruitingNCT07028073Phase 1/2
- Use of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"RecruitingNCT07021677Phase 2
- National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic LeukemiaRecruitingNCT07019766
- Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid MutationsRecruitingNCT07012447Phase 2
- CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute LeukemiaNot yet recruitingNCT07008872Not applicable
- a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid LeukemiaRecruitingNCT07007949Phase 2
- Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLRecruitingNCT07007312Phase 3
- Phase II Trial of Zanubrutinib, Obinutuzumab, Bendamustine (ZGB) as First-Line Therapy for Chronic Lymphocytic Leukemia: A Single-Center StudyNot yet recruitingNCT07003464Phase 2
- Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic LeukemiaRecruitingNCT06982274Phase 2
- XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid LeukemiaRecruitingNCT06980155Early Phase 1
- Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell LymphomaRecruitingNCT06961669Not applicable
- Mosaic Trial for Stem Cell Transplant RecipientsRecruitingNCT06960993Not applicable
- Clinical Study of rhTPO in Hematopoietic Stem Cell Mobilization for Autologous Transplantation in Acute LeukemiaNot yet recruitingNCT06955858Not applicable
- Music and VR Effects on Pain, Anxiety, and Fear During Oral Mucositis Care in Leukaemic ChildrenNot yet recruitingNCT06955338Not applicable
- JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ LeukemiaRecruitingNCT06940960Not applicable
- Evaluation of Functional and Nutritional Parameters in Fit Acute Leukemia PatientsRecruitingNCT06937554
- "Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALLRecruitingNCT06919393
- Hepatoprotective for Children and Adolescent With Acute Lymphoblastic LeukemiaRecruitingNCT06918054Phase 4
- Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta TestingRecruitingNCT06907797Not applicable
- Single Cell Acute Leukemia AnalysisNot yet recruitingNCT06906978Not applicable
- JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell LeukemiaNot yet recruitingNCT06902025Not applicable